BioImagene logo — company profile

BioImagene

Founded 2003 United States Sunnyvale, United States 37 employees Series D Total: $30.20M Biotechnology, Health Care

General Information

Company Name BioImagene
Founded Year 2003
Location United States Sunnyvale, United States +1
Employees 37
Industries Biotechnology, Health Care
Funding Stage Series D
Social

Get notified when BioImagene moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioImagene

BioImagene is a biotechnology and healthcare startup, founded in 2003 and headquartered in the United States. Acquired by Ventana Medical Systems in August 2010, it has since been a key player in delivering tissue-based diagnostic solutions for patients globally. The $26.00M Series D investment in August 19, 2008 involved prominent investors such as Artiman Ventures, Ascension Ventures, ICCP Venture Partners, Burrill & Company, and National Healthcare Services. Ventana's digital pathology, powered by BioImagene, offers comprehensive patient-focused solutions, enhancing workflow and efficiencies within pathology laboratories. This includes automated staining, image analysis, information management, and clinical lab optimization. With digital pathology solutions designed for academic medical centers, teaching hospitals, community hospitals, reference laboratories, and pharmaceutical and biotech companies, BioImagene plays a vital role in driving innovation in the healthcare industry.

Taxonomy: Diagnosis Solutions, Tissue-based Diagnostic, Digital Pathology, Automated Staining, Patient Reports, Image Analysis, Information Management, Clinical Labs, Pathology Workflow, Efficiency Improvement, Medical Centers, Hospitals, Laboratories, Pharmaceutical Industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 5
Investor Investor Investor Investor
•••• ••••
19 Aug 2008
Series B •••••• 3
Investor Investor
•••• ••••
12 Oct 2004

BioImagene Alternatives & Competitors

BioImagene vs

Excellence in patient care - every diagnosis, every day.

242 employees
Health Care
BioImagene vs

Arizona’s largest private pathology practice. Located in Tempe Arizona, Clin-Path is a local communi...

52 employees
Health Care
BioImagene vs

Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments a...

585 employees
Health Care, Information Technology

FAQ About BioImagene

Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. Ventana acquired BioImagene in August 2010. Through this acquisition, Ventana is uniquely positioned to deliver an end-to-end solution from aut...
BioImagene was founded in 2003.
BioImagene is headquartered in Sunnyvale, United States.
BioImagene operates in the following industries: Biotechnology, Health Care.
BioImagene has approximately 37 employees.
BioImagene has completed 2 funding rounds, raising a total of $30.20M. The latest funding stage is Series D.
Top alternatives and competitors to BioImagene include CellNetix Pathology and Laboratories, Clin-Path Diagnostics, L.L.C., Ventana Medical Systems, AppyStack Private Limited, OptraSCAN. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioImagene and CellNetix Pathology and Laboratories are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioImagene and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy